The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Neoplasia detection via colonoscopic surveillance among young patients with MSH6 and PMS2-associated Lynch syndrome.
 
Alicia Latham
No Relationships to Disclose
 
Ying L Liu
Research Funding - AstraZeneca (Inst); Repare Therapeutics (Inst); Tesaro/GSK (Inst)
Travel, Accommodations, Expenses - AstraZeneca
 
Gillain Constantino
No Relationships to Disclose
 
Matilde Borio
No Relationships to Disclose
 
Cole Poulin
No Relationships to Disclose
 
Sean McCoy
No Relationships to Disclose
 
Christina Dudzik
No Relationships to Disclose
 
Jordan Heiman
No Relationships to Disclose
 
Yelena Kemel
No Relationships to Disclose
 
Chinedu Ukaegbu
No Relationships to Disclose
 
Megha Ranganathan
No Relationships to Disclose
 
Madison Parenteau
No Relationships to Disclose
 
Sarah R. Kane
No Relationships to Disclose
 
Dina Green
No Relationships to Disclose
 
Jessica M. Long
Employment - DePuy Companies (I)
Stock and Other Ownership Interests - DePuy Companies (I)
 
Sapna Syngal
Patents, Royalties, Other Intellectual Property - Dana-Farber Cancer Institute has a registered service mark for the PREMM5 model and holds copyrights for the PREMM questionnaires (Inst); Myriad Genetics (through Dana-Farber Cancer Institute) paid an inventor share of the IP (license issue fee)
Expert Testimony - GlaxoSmithKline
 
Arnold Markowitz
No Relationships to Disclose
 
Zsofia Kinga Stadler
Consulting or Advisory Role - Adverum (I); Genentech/Roche (I); Gyroscope (I); Neurogene (I); Optos (I); Outlook Therapeutics (I); Regeneron (I); Regenxbio (I)
 
Matthew B. Yurgelun
Consulting or Advisory Role - Janssen
Research Funding - Janssen Oncology
Other Relationship - UpToDate
 
Bryson W Katona
Other Relationship - Epigenomics; Freenome; Guardant Health; Immunovia; Janssen; Universal Diagnostics
(OPTIONAL) Uncompensated Relationships - Ambry Genetics; GenDx; InVitae